Willcox N
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
Curr Opin Immunol. 1993 Dec;5(6):910-7. doi: 10.1016/0952-7915(93)90105-2.
The cause of the myasthenics' pathogenic autoantibody response against the muscle acetylcholine receptor is an intriguing puzzle involving the thymus and its epithelial tumours, and possibly a variety of cross-reacting epitopes. Another fascinating challenge is to find ways of selectively inhibiting this response in the patients.